NCT06864494View on ClinicalTrials.gov

Determination of Lipocalin Type-prostaglandin (L-PGDS) in Blood, Urine, Vaginal Samples and Endometrial Ablation by Enzyme-linked Immunosorbent Assay

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

June 25, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
AdenomyosisEndometriosis
Interventions
PROCEDURE

Endometrial ablation

Performed using a transfer catheter (used for embryo transfers) positioned at the level of the internal cervical orifice in the uterine cavity. Five ml of saline will be injected and collected in a dry tube

Trial Locations (1)

30029

RECRUITING

CHU de Nimes, Nîmes

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nīmes

OTHER

NCT06864494 - Determination of Lipocalin Type-prostaglandin (L-PGDS) in Blood, Urine, Vaginal Samples and Endometrial Ablation by Enzyme-linked Immunosorbent Assay | Biotech Hunter | Biotech Hunter